ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 307

Biochemical Intervertebral Disc Alterations in Patients with Low Back Pain and Radiculopathy

Philipp Sewerin1, Christoph Schleich2, Ruben Sengewein3, Matthias Schneider4 and Benedikt Ostendorf1, 1Department and Hiller-Research-Unit for Rheumatology, Heinrich-Heine University, Düsseldorf, Germany, 2Dep. for diagnostic and interventional Radiology, Heinrich-Heine University, Duesseldorf, Germany, 3Department and Hiller Research Unit for Rheumatology, Heinrich-Heine University, Düsseldorf, Germany, 4Policlinic for Rheumatology & Hiller Research Centre for Rheumatology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Back pain, degenerative arthritis and spine involvement, MRI

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Orthopedics, Low Back Pain and Rehabilitation Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: To assess the glycosaminoglycan (GAG) content of lumbar intervertebral discs (IVD) in patients with low back pain (LBP) and radiculopathy using glycosaminoglycan chemical exchange saturation transfer imaging (gagCEST).

Methods: 258 lumbar IVDs of 53 participants, 21 healthy volunteers, 19 patients with LBP and 13 patients with radiculopathy (28 female; 25 male; mean age: 45.5 ± 16.7 years; range: 23 – 83 years), were examined with a 3T MRI scanner. Biochemical gagCEST imaging was used to determine the GAG content of each nucleus pulposus (NP) and annulus fibrosus (AF).

Results: Significantly reduced gagCEST values of NP were found in patients with LBP and/or radiculopathy (p < 0.0001) compared to healthy control group. NP gagCEST values were significantly lower in patients with LBP (p < 0.0001) and radiculopathy (p = 0.0005) compared to healthy volunteers, respectively. We saw an association between pain and GAG loss with significantly lower gagCEST values in participants with dorsal pain at examination day (p = 0.0004) and higher pain scores (p < 0.0001) compared to participants without LBP. Participants with body mass index ≥ 25 revealed lower gagCEST values compared to participants with BMI < 25 (p = 0.02).

Conclusion: GagCEST analysis indicated significantly lower GAG values of NP in patients with LBP or radiculopathy, in participants with elevated BMI, current pain at examination day and elevated pain scores.


Disclosure: P. Sewerin, None; C. Schleich, None; R. Sengewein, None; M. Schneider, None; B. Ostendorf, None.

To cite this abstract in AMA style:

Sewerin P, Schleich C, Sengewein R, Schneider M, Ostendorf B. Biochemical Intervertebral Disc Alterations in Patients with Low Back Pain and Radiculopathy [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/biochemical-intervertebral-disc-alterations-in-patients-with-low-back-pain-and-radiculopathy/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/biochemical-intervertebral-disc-alterations-in-patients-with-low-back-pain-and-radiculopathy/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology